The Latest Breaking News from Gold

With the technology ecosystem — including the previously red-hot cryptocurrency sector — suffering a worrying correction, investors have found comfort in traditional safe havens. On paper, that would mean gold but precious metals have also been fading recently. Instead, it's defensive enterprises like Procter Gamble (NYSE:PG) that have witnessed an…

While artificial intelligence may dominate headlines, it's the gold market that deserves everyone's attention — at least that's the argument forwarded by renowned macro investor Ray Dalio. With the world order shifting and debt assets' risk profile rising, gold has emerged as the superior store of wealth. As such, bullion…

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Friday.

As economic uncertainty deepens, the rush for gold continues — with prices for the precious metal topping $4,300 for the first time this week

Gold surged past $4,300/oz in a record rally, stoking fears about the US economy and sending global markets scrambling for safe-havens amid mounting credit and Fed uncertainty.

Berkshire Hathaway chair Warren Buffett has long criticised gold because it does not generate cash flow. However, Berkshire briefly held a $500 million stake in a gold mining company at the height of the pandemic.

Hedge fund manager Ray Dalio has been one of the biggest proponents of investing in gold in recent years. That bet is paying off nicely in 2025 with gold at record high prices.

Gold is on fire, marking its hottest year since 1979, and Fresnillo Plc (OTCPK: FNLPF) is riding the wave.

The dollar index (DXY00 ) today is up by +0.17%. The dollar recovered from a 1-week low today and turned higher, as concerns eased over the credit quality of US regional banks. The dollar rose as the alleged loan frauds tied to Zions Bancorp and Western Alliance Bancorp appear to...

President Donald Trump just dropped a political bomb into one of Wall Street's hottest trades. His promise to cut the cost of Novo Nordisk A/S (NYSE:NVO) blockbuster drug Ozempic from around $1,300 to $150 isn't just about affordability—it's about shaking the foundations of the GLP-1 gold rush that's reshaped healthcare…

Gold and tech stocks—the world's oldest safe haven and its most speculative growth engine—are surprisingly rising in tandem, defying decades of market logic and setting the stage for what could be an inevitable break.